WAVE Life Sciences (WVE) Misses Q4 EPS by 10c

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.61), $0.10 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $15.79 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• How big a risk are rates to the AI boom?
• BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel